Sustainability Report

Overview

The report describes Yifan Pharmaceutical's 2025 ESG governance formalization, including the establishment of an ESG Management System and Board-led sustainability oversight. It highlights continued Ryzneuta® innovation, global commercialization and expanded healthcare access. The report discloses 109,782.35 tCO2e of total greenhouse gas emissions, alongside workforce, safety and resource metrics, and includes a limited-assurance report over selected key data.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Publication date: 22 April 2026
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services